Carcinoma In Situ (cis) - Epidemiology

Relevant Publications

N-803 Plus BCG Treatment for BCG-Naïve or -Unresponsive Non-Muscle Invasive Bladder Cancer: A Plain Language Review.

Issue Release: 2024

Efficacy of Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial.

Issue Release: 2024

Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor.

Issue Release: 2024

Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?

Issue Release: 2024

The sensitivity of laryngeal findings in predicting high-grade dysplasia in patients with vocal fold leukoplakia undergoing office-based biopsies: A retrospective analysis of 100 cases.

Issue Release: 2024

Radiotherapy Combined with a Radiosensitizer for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Carcinoma In Situ Bladder Cancer: An Open-label, Single-arm, Multicenter, Phase 2 European Organisation for Research and Treatment of Cancer Trial.

Issue Release: 2024

Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists.

Issue Release: 2024

Nogapendekin alfa Inbakicept: First Approval.

Issue Release: 2024

Impact of bladder cancer family history on the prognosis of patients with Non-Muscle Invasive bladder cancer Treated with Bacillus Calmette-Guerin (BCG).

Issue Release: 2024

Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?

Issue Release: 2024

A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment.

Issue Release: 2024

The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases.

Issue Release: 2024

A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder.

Issue Release: 2024

Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.

Issue Release: 2024

PROSPECTIVE EVALUATION OF SURGICAL MARGINS IN NON-MUSCLE INVASIVE BLADDER CANCER FOLLOWING PRIMARY TRANSURETHRAL RESECTİON.

Issue Release: 2024

Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer.

Issue Release: 2024

Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer.

Issue Release: 2024

Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer.

Issue Release: 2024

Bacillus Calmette-Guérin (BCG)-Induced Pneumonitis: A Case Report.

Issue Release: 2024

Unveiling the Clinical Path of Microinvasive Breast Cancer: A Comparative Study With Tis-T1 Breast Cancer.

Issue Release: 2024

What are the Challenges to Enhanced Interoperability?

What Role Does Adaptive Optics Play in Epidemiological Studies?

What are the Preventive Measures for Aerosol-Related Infections?

How is Behavioral Support Implemented?

Why are Guidelines and Standards Important?

How is Vitamin C Deficiency Diagnosed?

What Challenges Exist in COVID-19 Reporting?

What is the Future of Biotechnology in Epidemiology?

How to Interpret the Results?

Why is Shuffling Important?

Carcinoma In Situ (cis) - Epidemiology

Relevant Publications

Partnered Content Networks

Relevant Topics